Abstract

To distinguish the disease and medication opposition of Mycobacterium tuberculosis (MTB) in Chongqing and give a logical premise to the counteractive action and treatment of tuberculosis. DNA was gathered from all new presumed patients in Chongqing from January 2014 to September 2017, Genechip innovation was utilized to recognize Mtb strain. Genechip innovation recognizes transformations in the ropB quality (related with protection from rifampicin) at locus 511, locus 513, locus 516 locus 526, locus 531 or locus 533. Genechip innovation was likewise used to distinguish changes in the KatG quality and inhA quality. Genechip uncovered that the Mtb tainted male represented 73.98% and female represented 26.12%. The all-out medication obstruction rate of rifampicin and isoniazid were 11.2% (122/110771). Genechip uncovered that ropB quality of 72 strains were change. The most astounding transformation site was 531 (TCG) locus (37.5%, 27/72). The general population with katG and inhA quality change were 50 patients. The most widely recognized transformation site was 315 (AGC) locus. The pit, history of treatment, and sporadic prescription were the hazard factor of medication safe Mtb. Our report showed the contaminated proportion and the medication safe kinds of Mtb in Chongqing region. We ought to reinforce wellbeing the board and give psychosocial support, so as to lessen the danger of medication safe Mtb